Identification of MDK as a Hypoxia- and Epithelial-Mesenchymal Transition-Related Gene Biomarker of Glioblastoma Based on a Novel Risk Model and In Vitro Experiments.

基于新型风险模型和体外实验，鉴定MDK为胶质母细胞瘤缺氧和上皮间质转化相关基因生物标志物